This book summarizes the synthesis, properties, characterization, and application of viral and antiviral nanomaterials by using interdisciplinary subjects ranging from materials science to biomedical science. Viral and Antiviral Nanomaterials: Synthesis, Properties, Characterization, and Application highlights attainments in utilizing nanomaterials as powerful tools for the treatment of viral infections in plants, animals, and humans. It reviews the adopted strategies for designing viral and antiviral nanomaterials for medical applications, including cancer therapy and drug delivery. It also explains the different kinds of antiviral nanosized structures, their chemistries, and the attributes that enable them to be suitable targets for nanotherapeutics. The contributors have prepared the content in a comprehensive manner for readers to use their research findings to improve the healthcare of all living beings.
FEATURES
Reviews the novel tools for synthesis and characterization of nanomaterials as viral and antiviral agents
Explores the different applications of currently available nanomaterials for the treatment of viral infections
Investigates the role of antiviral nanodrugs in human and plant systems
Addresses the activity of nanostructures in drug-delivery systems for cancer treatment
Allows readers from various backgrounds to access the advanced research and practices across traditional frontiers
Discusses viral nanomaterials as the viable future of antiviral drugs and nanovaccines in animals and humans
This authoritative book is of exceptional relevance to postgraduate scholars, researchers, and scientists interested in nanomedicine, biomedical science, materials science, biopharmaceutical technology, microbiology, and virology to improve virus- and cancer-based therapeutic tools for animal and human welfare.
| Preface |
|
xi | |
| Editors |
|
xiii | |
| Contributors |
|
xv | |
|
SECTION I Nanosized Materials in Virology |
|
|
|
Chapter 1 Viruses as Nanomaterials |
|
|
3 | (38) |
|
|
|
|
|
|
|
Chapter 2 Synthesis and Characterization of Nanoparticles as Potential Viral and Antiviral Agents |
|
|
41 | (22) |
|
|
|
Sindhu Thalappan Manikkoth |
|
|
|
|
|
|
|
|
Baiju Kizhakkekilikoodayil Vijayan |
|
|
Chapter 3 Biogenic Synthesis of Nanoparticulate Materials for Antiviral Applications |
|
|
63 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Chapter 4 Nanoparticle Synthesis and Administration Routes for Antiviral Uses |
|
|
77 | (24) |
|
Joao Augusto Oshiro-Junior |
|
|
Kammila Martins Nicolau Costa |
|
|
|
|
Bruna Galdorfini Chiari-Andreo |
|
|
Chapter 5 Role of Nanostructures in Inhibition and Treatment of Viral Infections |
|
|
101 | (24) |
|
|
|
|
|
SECTION II Viral Nanomaterials: Biomedical Applications |
|
|
|
Chapter 6 Photocatalytic Inactivation of Pathogenic Viruses Using Metal Oxide and Carbon-Based Nanoparticles |
|
|
125 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Chapter 7 Non-Photocatalytic and Photocatalytic Inactivation of Viruses Using Antiviral Assays and Antiviral Nanomaterials |
|
|
139 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Chapter 8 Application of Viral Nanomaterials in Medicine |
|
|
165 | (8) |
|
|
|
|
|
Chapter 9 Virus-Based Nanocarriers for Targeted Drug Delivery |
|
|
173 | (22) |
|
|
|
|
|
|
|
|
|
SECTION III Antiviral Nanotherapeutics |
|
|
|
Chapter 10 Antiviral Nanomaterials in Therapeutic Interventions |
|
|
195 | (18) |
|
|
|
|
|
Chapter 11 In Vivo Study of Anti-Influenza Effect of Silver Nanoparticles in a Mouse Model |
|
|
213 | (16) |
|
|
|
|
|
|
|
|
|
Chapter 12 Antiviral Drugs as Tools for Nanomedicine |
|
|
229 | (36) |
|
|
|
|
|
Chapter 13 Emerging Nanotechnology-Enabled Approaches to Mitigate COVID-19 Pandemic |
|
|
265 | (20) |
|
|
|
|
|
|
|
|
|
|
|
Chapter 14 Applications of Antiviral Nanoparticles in Cancer Therapy |
|
|
285 | (22) |
|
|
|
|
|
|
|
|
|
Chapter 15 Nano Delivery of Antiviral Plant Bioactives as Cancer Therapeutics |
|
|
307 | (44) |
|
|
|
|
|
Manickam Senguttuvan Swetha |
|
|
|
|
Chapter 16 Conjugated Graphene Gold Nanocomposites for Cancer Therapy |
|
|
351 | (26) |
|
|
|
|
|
Shahjalal Mohammad Shibly |
|
|
|
|
|
|
|
|
Chapter 17 Surface Engineered Graphene Oxide and Its Derivatives: A Prospective Nano-Structured Carbon as Anticancer Agent |
|
|
377 | (24) |
|
|
|
|
|
Shahjalal Mohammad Shibly |
|
|
|
|
|
|
|
|
Chapter 18 Antiviral Nanomaterials as Potential Targets for Malaria Prevention and Treatment |
|
|
401 | (24) |
|
|
|
|
|
|
|
|
|
|
| Index |
|
425 | |
Devarajan Thangadurai, PhD, is Assistant Professor at Karnatak University, Dharwad in India and did his postdoctoral research at the University of Madeira, Portugal, University of Delhi, India, and ICAR National Research Centre for Banana, India. He is the recipient of Best Young Scientist Award with Gold Medal from Acharya Nagarjuna University, India, and the VGST-SMYSR Young Scientist Award of the Government of Karnataka, India. He has interest and expertise in the fields of biotechnology and nanotechnology for sustainable future. He has authored/edited more than twenty five books with international publishers in USA, Canada, Switzerland and India. He has authored/coauthored 210 publications inclusive of journal articles, book chapters, books and invited presentations. He has extensively travelled to many universities and institutes in Africa, Europe and Asia for academic works, scientific meetings, and international collaborations.
Saher Islam, PhD, is an HEC Scholar (Higher Education Commission) of the Islamic Republic of Pakistan at the University of Veterinary and Animal Sciences, Lahore, where she received her BS, MPhil and PhD in Molecular Biology, Biotechnology and Bioinformatics. She is IRSIP Scholar at Cornell University, New York and Visiting Scholar at West Virginia State University, West Virginia in USA. She has keen research interests in genetics, molecular biology, biotechnology, and bioinformatics pertaining to animal, dairy and food science, and has ample hands on experience in molecular marker analysis, whole genome sequencing and RNA sequencing. She has visited USA, UK, Singapore, Germany, Italy and Russia for academic and scientific trainings, courses, and meetings. She is the recipient of 2016 Boehringer Ingelheim Fonds Travel Grant from European Molecular Biology Laboratory, Germany. She is an author/coauthor of 50 publications including journal articles, book chapters, books and conference presentations.
Charles Oluwaseun Adetunji, PhD, is presently the Ag. Director of Intellectual Properties and Technology Transfer; Chairman Committee on Research Grant and Associate Professor of Microbiology and Biotechnology at EUI. He has won several scientific awards and grants from renowned academic bodies like Council of Scientific and Industrial Research (CSIR) India, and Department of Biotechnology (DBT) India, The World Academy of Science (TWAS) Italy, Netherlands Fellowship Programme (NPF) Netherlands, The Agency for International Development Cooperation Israel, Royal Academy of Engineering UK among many others. He has filed several scientific patents on nanobiosurfactants, nanobiopesticdes and many more. He has published over 150 scientific journals and conference proceedings in international and local refereed journals. His research interest includes microbiology, biotechnology, post-harvest management, and nanotechnology. He is an editorial board member of many international journals and serves as a reviewer to many double-blind peer review journals of Elsevier, Springer, Taylor and Francis, Wiley, PLOS One, Nature, American Chemistry Society, Bentham Science Publishers etc. He is a member of many scientific and professional bodies like American Society for Microbiology, Nigerian Young Academy, Biotechnology Society of Nigeria, and Nigerian Society for Microbiology. He has won international recognition and also acted as a keynote speaker delivering invited talk/position paper at various universities, research institutes and several centers of excellence which span across several continent of the globe. He has over the last fifteen years built strong working collaborations with reputable research groups in numerous and leading Universities across the globe. He is the convener for Recent Advances in Biotechnology, which is an annual international conference where renowned microbiologists and biotechnologists come together to share their latest discoveries. He is also the Founder & CEO of BECTIK Biotechnology and Nanotechnology Company.
